Location History:
- Sint-Andries, BE (2021)
- Ghent, BE (2023)
Company Filing History:
2 out of 223 
2 out of 489 
1 out of 2 Years Active: 2021-2023
Title: Emma Persson: Innovator in Antibody Research
Introduction
Emma Persson is a notable inventor based in Sint-Andries, Belgium. She has made significant contributions to the field of antibody research, particularly focusing on galectin-10. With a total of 2 patents, her work is paving the way for advancements in medical treatments.
Latest Patents
Emma's latest patents include innovative antagonists that specifically target the protein galectin-10. These antibodies and their antigen-binding fragments are designed to disrupt the crystallization of galectin-10. This disruption is crucial for developing methods to prevent and treat diseases associated with the formation of Charcot-Leyden crystals (CLCs). Her research holds promise for addressing various health conditions linked to this pathology.
Career Highlights
Throughout her career, Emma has worked with reputable organizations such as Vib Vzw and Universiteit Gent. Her experience in these institutions has allowed her to collaborate with other experts in the field and further her research endeavors.
Collaborations
Emma has collaborated with notable colleagues, including Jean-Michel Percier and Christophe Blanchetot. These partnerships have enriched her work and contributed to her innovative research.
Conclusion
Emma Persson is a pioneering inventor whose work on galectin-10 antibodies is making a significant impact in the medical field. Her contributions are essential for advancing treatments for diseases linked to Charcot-Leyden crystals.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.